Herrmann K - Search Results

1

Oncologic PET/CT interpretation and reporting approaches. Survey in clinical practice.

Karantanis D, Kalkanis D, Allen-Auerbach MS, Herrmann K, Pomykala KL, Bogsrud TV, Lowe VJ, Czernin J. Karantanis D, et al. Among authors: herrmann k. Nuklearmedizin. 2014;53(2):19-25. doi: 10.3413/Nukmed-0613-13-07. Epub 2014 Jan 29. Nuklearmedizin. 2014. PMID: 24473996

2

Economic evaluation of PET and PET/CT in oncology: evidence and methodologic approaches.

Buck AK, Herrmann K, Stargardt T, Dechow T, Krause BJ, Schreyögg J. Buck AK, et al. Among authors: herrmann k. J Nucl Med Technol. 2010 Mar;38(1):6-17. doi: 10.2967/jnmt.108.059584. J Nucl Med Technol. 2010. PMID: 20197541 Free article. Review.

3

(18)F-FDG PET/CT for monitoring treatment responses to the epidermal growth factor receptor inhibitor erlotinib.

Benz MR, Herrmann K, Walter F, Garon EB, Reckamp KL, Figlin R, Phelps ME, Weber WA, Czernin J, Allen-Auerbach MS. Benz MR, et al. Among authors: herrmann k. J Nucl Med. 2011 Nov;52(11):1684-1689. doi: 10.2967/jnumed.111.095257. J Nucl Med. 2011. PMID: 22045706 Free PMC article. Clinical Trial.

4

(18)F-FDG-PET/CT in evaluating response to therapy in solid tumors: where we are and where we can go.

Herrmann K, Benz MR, Krause BJ, Pomykala KL, Buck AK, Czernin J. Herrmann K, et al. Q J Nucl Med Mol Imaging. 2011 Dec;55(6):620-32. Q J Nucl Med Mol Imaging. 2011. PMID: 22231582 Review.

5

18F-FDG-PET/CT Imaging as an early survival predictor in patients with primary high-grade soft tissue sarcomas undergoing neoadjuvant therapy.

Herrmann K, Benz MR, Czernin J, Allen-Auerbach MS, Tap WD, Dry SM, Schuster T, Eckardt JJ, Phelps ME, Weber WA, Eilber FC. Herrmann K, et al. Clin Cancer Res. 2012 Apr 1;18(7):2024-31. doi: 10.1158/1078-0432.CCR-11-2139. Epub 2012 Feb 14. Clin Cancer Res. 2012. PMID: 22338012 Free PMC article.

6

(18) F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of recurrent bone and soft tissue sarcoma.

Al-Ibraheem A, Buck AK, Benz MR, Rudert M, Beer AJ, Mansour A, Pomykala KL, Haller B, Juenger H, Scheidhauer K, Schwaiger M, Herrmann K. Al-Ibraheem A, et al. Among authors: herrmann k. Cancer. 2013 Mar 15;119(6):1227-34. doi: 10.1002/cncr.27866. Epub 2012 Dec 11. Cancer. 2013. PMID: 23233156 Free article.

7

Evaluation of the Genisys4, a bench-top preclinical PET scanner.

Herrmann K, Dahlbom M, Nathanson D, Wei L, Radu C, Chatziioannou A, Czernin J. Herrmann K, et al. J Nucl Med. 2013 Jul;54(7):1162-7. doi: 10.2967/jnumed.112.114926. Epub 2013 Apr 29. J Nucl Med. 2013. PMID: 23628700 Free PMC article.

8

The potential of PET/MRI imaging in oncology: a comment to a summary report of the First PET/MRI Workshop in Tuebingen in 2012.

Czernin J, Herrmann K. Czernin J, et al. Among authors: herrmann k. Mol Imaging Biol. 2013 Aug;15(4):372-3. doi: 10.1007/s11307-013-0642-y. Mol Imaging Biol. 2013. PMID: 23689984 Free PMC article. No abstract available.

9

Tumor localization in ectopic Cushing syndrome using combined PET/CT imaging.

Bluemel C, Lapa C, Mottok A, Hahner S, Herrmann K. Bluemel C, et al. Among authors: herrmann k. Clin Nucl Med. 2013 Sep;38(9):749-51. doi: 10.1097/RLU.0b013e31829962d3. Clin Nucl Med. 2013. PMID: 23816940

10

Three-phase bone scintigraphy for imaging osteoradionecrosis of the jaw.

Lapa C, Linz C, Bluemel C, Mottok A, Mueller-Richter U, Kuebler A, Schneider P, Czernin J, Buck AK, Herrmann K. Lapa C, et al. Among authors: herrmann k. Clin Nucl Med. 2014 Jan;39(1):21-5. doi: 10.1097/RLU.0000000000000296. Clin Nucl Med. 2014. PMID: 24300350

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,346 results

Search Page